Literature DB >> 15034755

Inhibition of gamma-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma.

P Ruoso1, D W Hedley.   

Abstract

PURPOSE: To determine whether gamma-glutamyl transpeptidase (gamma-GT) is involved in the maintenance of elevated cysteine levels in cervical carcinoma.
METHODS: Four cervical carcinoma cell lines were tested in vitro for cysteine accumulation and gamma-GT levels. The highest and lowest gamma-GT-expressing cell lines were used in in vivo experiments to determine the effect of gamma-GT inhibition on cysteine levels.
RESULTS: Treatment of a series of cervical carcinoma cell lines with acivicin decreased intracellular cysteine concentrations. Cysteine depletion was evident in Me180 cells which had the greatest levels of gamma-GT activity, and had a more pronounced cysteine decrease in medium with glutathione and cysteine concentrations simulating the in vivo situation. Also investigated were the effects of inhibition of gamma-GT activity on intracellular cysteine levels in xenografts grown in severe combined immunodeficient (SCID) mice. With the use of 35 mg/kg of acivicin, gamma-GT activity decreased to basal levels of detection in both tumour types and significant decreases in cysteine levels were seen in the high gamma-GT-expressing tumours (Me180). Thus, inhibition of gamma-GT activity may have therapeutic potential in high-expressing cancers.
CONCLUSIONS: In tumours and cell lines with elevated levels of gamma-GT activity, inhibition of this enzyme led to decreases of cysteine levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034755     DOI: 10.1007/s00280-004-0776-3

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  8 in total

Review 1.  γ-Glutamyltranspeptidases: sequence, structure, biochemical properties, and biotechnological applications.

Authors:  Immacolata Castellano; Antonello Merlino
Journal:  Cell Mol Life Sci       Date:  2012-04-21       Impact factor: 9.261

2.  Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression.

Authors:  Ankita Bansal; Danielle J Sanchez; Vivek Nimgaonkar; David Sanchez; Romain Riscal; Nicolas Skuli; M Celeste Simon
Journal:  Mol Cancer Res       Date:  2019-05-31       Impact factor: 5.852

3.  Divergent effects of compounds on the hydrolysis and transpeptidation reactions of γ-glutamyl transpeptidase.

Authors:  Stephanie Wickham; Nicholas Regan; Matthew B West; Vidya Prasanna Kumar; Justin Thai; Pui Kai Li; Paul F Cook; Marie H Hanigan
Journal:  J Enzyme Inhib Med Chem       Date:  2011-08-24       Impact factor: 5.051

4.  Sulfur-containing histidine compounds inhibit γ-glutamyl transpeptidase activity in human cancer cells.

Authors:  Mariarita Brancaccio; Maria Russo; Mariorosario Masullo; Anna Palumbo; Gian Luigi Russo; Immacolata Castellano
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

5.  A novel, species-specific class of uncompetitive inhibitors of gamma-glutamyl transpeptidase.

Authors:  Jarrod B King; Matthew B West; Paul F Cook; Marie H Hanigan
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

Review 6.  Gamma-glutamyl transpeptidase: redox regulation and drug resistance.

Authors:  Marie H Hanigan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

7.  Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense.

Authors:  Martin Joyce-Brady; Jun Hiratake
Journal:  Curr Enzym Inhib       Date:  2011-07

8.  Acceleration of anaerobic cysteine transformations to sulfane sulfur consequent to γ-glutamyl transpeptidase inhibition.

Authors:  Inga Kwiecień; Małgorzata Iciek; Lidia Włodek
Journal:  ScientificWorldJournal       Date:  2012-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.